VRS
ABUS icon

Virginia Retirement Systems’s Arbutus Biopharma ABUS Stock Holding History

Virginia Retirement Systems’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$98.6K Sell
20,500
-700
-3% -$3.15K ﹤0.01% 942
2025
Q3 		$96.2K Sell
21,200
-15,100
-42% -$55.5K ﹤0.01% 922
2025
Q2 		$112K Sell
36,300
-3,300
-8% -$11K ﹤0.01% 925
2025
Q1 		$138K Buy
+39,600
New +$132K ﹤0.01% 985

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Virginia Retirement Systems's ABUS Position: Q4 2025 in Review

Virginia Retirement Systems reduced its Arbutus Biopharma (ABUS) stake by 3.3% in Q4 2025, selling an estimated $3.15K and leaving 20,500 shares worth $98.6K. The position accounts for ﹤0.01% of the portfolio, ranked #942.

Virginia Retirement Systems first reported a position in ABUS in Q1 2025 and has held it in 4 quarters since. The position peaked at $138K in Q1 2025. 172 funds tracked by Wall St. Rank hold ABUS as of Q4 2025.

  • Virginia Retirement Systems held 20,500 shares of Arbutus Biopharma worth $98.6K as of Q4 2025.
  • Virginia Retirement Systems sold 700 Arbutus Biopharma shares in Q4 2025, an estimated $3.15K.
  • Arbutus Biopharma made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #942 holding.
  • Virginia Retirement Systems first reported a position in Arbutus Biopharma in Q1 2025 and has held it in 4 quarters since.
  • Virginia Retirement Systems's Arbutus Biopharma position peaked at $138K in Q1 2025.
  • 172 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.